Drug Stewardship

Information for Health Professionals

About

Drug Stewardship within Alberta Health Services is defined as the effective, safe, and sustainable use of medications by all staff and physicians. The Drug Stewardship Pharmacists have zonal responsibilities, but they focus on provincewide activities through working with stakeholders to develop and execute initiatives.

Resources provided here are available for all staff and physicians to access.

Drug Stewardship Initiatives

Contact

If you have any questions or concerns, please contact us:
Email: AHS.PharmacyDrugStewardship@ahs.ca

Iron Stewardship

Background

Iron deficiency anemia (IDA) is an important medical condition that has been shown to impact mortality and quality of life across many patient populations. Perioperative anemia lengthens recovery time and length of stay. While, iron deficiency anemia in pregnancy increases the risk of preterm delivery, caesarean section, and long term newborn cognitive/motor/memory issues.

The goals of the Iron Stewardship initiative is to support clinically appropriate parenteral iron use. Using the tools below, the healthcare team can examine viable clinical alternatives to parental iron. Thus allowing for consistent, appropriate treatment of IDA across care settings.

Tools

Contact

If you have any questions or concerns, please contact us:
Email: AHS.PharmacyDrugStewardship@ahs.ca

Proton Pump Inhibitor Deprescribing

Background

Proton pump inhibitors (PPIs) are one of the most commonly prescribed medications in Canada and are effective in the management of a variety of conditions such as gastroesophageal reflux disease (GERD), dyspepsia, Barrett’s esophagus, esophagitis and Helicobacter pylori associated gastric and peptic ulcers. Even though many indications require short term therapy there is growing concern about the overuse of PPI’s and the risks and adverse events associated with long term use. Studies assessing PPI use report up to 60% of patients taking a PPI may not have a proper indication for long term use. Choosing Wisely Canada guidelines recommend that an attempt should be made to stop/reduce PPIs in most patients on therapy for gastrointestinal symptoms at least once a year as they are often used inappropriately without an indication and for longer durations than recommended.

The goals of the Proton pump inhibitors deprescribing initiative is to promote the appropriate use of PPI’s including indication, dose and treatment duration. Using the tools created the healthcare team of can support the deprescribing PPIs

Tools

Contact

If you have any questions or concerns, please contact us:
Email: AHS.PharmacyDrugStewardship@ahs.ca